INVITE-ONLY SCRIPT

TENKAN BOLT

已更新
TENKAN BOLT

7 major point in this indicator are as follows :-
•Tenkan-sen
•Ichimoku Cloud
•Exponential Moving Average
•Change of Volume Analysis (calculated in background)
•Modified Keltner Channel (calculated in background)
•RSI Divergence (calculated in background)
•Entry and Exit Point

https://www.tradingview.com/chart/L0QFgK3T/?symbol=MYX%3AFCPO1%21
There will be 2 types of Long entry alert and 2 types of Short entry alert.
•The first one is marked as "Long" or "Short" only which indicates the signal calculated by Keltner Channel, Tenkan-sen and change of volume in sudden time.
•The second one is marked as "Long Divergence" and "Short Divergence" which indicates signal by RSI Divergence in my own way (not aggressive).

The idea of this script is only trade the highest probability setup and I shall call it the "High Probability, Probability Trading". This is definitely not a buy or sell call as the idea of the script is to give a good direction for trader and to learn the high probability trading setup which includes the volatility of the market.

This script specifically created for Futures Crude Palm OIL (FCPO) market and may works differently in different market. It works great in 1 minute time-frame and 3 minute time-frame
(with slight adjustment).

Kindly contact me for usage. Thanks!
發布通知
New Condition Added as follows :-
  • Counter trend during market opening
  • Risk and Reward ratio updated.
  • Trail stop updated
  • User can customize Long and Short condition based on preferences
發布通知
  • Updated entry condition
  • Update risk to reward ratio (non slippage). Kindly use the option for better winning percentage https://ibb.co/SxTxrYQ
    Thank you and have fun!
fcpoOscillatorsTrend Analysis

僅限邀請腳本

僅限作者授權的用戶訪問此腳本,並且通常需要付費。您可以將其增加到收藏腳本中,但是只有在向作者請求並獲得許可之後,才能使用它。 請聯繫ShukAzriy以了解更多信息,或按照下面作者的說明進行操作。

TradingView 不建議購買並使用此腳本,除非您 100% 信任其作者並了解腳本的工作原理。在許多情況下,您可以在我們的社群腳本中免費找到良好的開源替代方案。

作者的說明

Kindly request access by direct message/personal message

想在圖表上使用此腳本?

警告:請閱讀,然後再請求訪問權限。

免責聲明